Ubiquitin proteolytic system: focus on SUMO

References

• Herrmann J, Lerman LO, Lerman A. Ubiquitin and ubiquitin-like proteins in protein regulation. Circ. Res.100, 1276–1291 (2007).
   PubMed Web of Science ®Google Scholar
• Melchior F. SUMO – nonclassical ubiquitin. Ann. Rev. Cell Develop. Biol.16, 591–626 (2000).
   PubMed Web of Science ®Google Scholar
• Desterro JM, Thomson J, Hay RT. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett.417, 297–300 (1997).
   PubMed Web of Science ®Google Scholar
• Saitoh H, Sparrow DB, Shiomi T et al. Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2. Curr. Biol.8, 121–124 (1998).
   PubMedGoogle Scholar
• Kerscher O. SUMO junction – what’s your function? New insights through SUMO-interacting motifs. EMBO Rep.8, 550–555 (2007).
   PubMed Web of Science ®Google Scholar
• Hay RT. SUMO: a history of modification. Mol. Cell18, 1–12 (2005).
   PubMed Web of Science ®Google Scholar
• Seeler JS, Bischof O, Nacerddine K, Dejean A. SUMO, the three Rs and cancer. Curr. Top. Microbiol. Immunol.313, 49–71 (2007).
   PubMedGoogle Scholar
• Gong LM, Millas S, Maul GG, Yeh ETH. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem.275, 3355–3359 (2000).
   PubMed Web of Science ®Google Scholar
• Kim KI, Baek SH, Jeon YJ et al. A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J. Biol. Chem.275, 14102–14106 (2000).
   PubMed Web of Science ®Google Scholar
• Best JL, Ganiatsas S, Agarwal S et al. SUMO-1 protease-1 regulates gene transcription through PML. Mol. Cell10, 843–855 (2002).
   PubMedGoogle Scholar
• Nishida T, Kaneko F, Kitagawa M, Yasuda H. Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat Axam, which is an Axin-binding protein promoting β-catenin degradation. J. Biol. Chem.276, 39060–39066 (2001).
   PubMedGoogle Scholar
• Kadoya T, Yamamoto H, Suzuki T et al. Desumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of b-catenin. Mol. Cell. Biol.22, 3803–3819 (2002).
   PubMedGoogle Scholar
• Saitoh H, Pu RT, Dasso M. SUMO-1: wrestling with a new ubiquitin-related modifier. Trends Biochem. Sci.22, 374–376 (1997).
   PubMed Web of Science ®Google Scholar
• Yeh ET, Gong L, Kamitani T. Ubiquitin-like proteins: new wines in new bottles. Gene248, 1–14 (2000).
   PubMed Web of Science ®Google Scholar
• Jones D, Crowe E, Stevens TA, Candido EPM. Functional and phylogenetic analysis of the ubiquitylation system in Caenorhabditis elegans: ubiquitin-conjugating enzymes, ubiquitin-activating enzymes, and ubiquitin-like proteins. Genome Biol.3, 2.1–2.15 (2001).
   Google Scholar
• Nacerddine K, Lehembre F, Bhaumik M et al. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Develop. Cell9, 769–779 (2005).
   PubMed Web of Science ®Google Scholar
• Zhao J. Sumoylation regulates diverse biological processes. Cell. Mol. Life Sci.19, 350–355 (2007).
   Google Scholar
• Jakobs A, Koehnke J, Himstedt F et al. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation. Nat. Methods4, 245–250 (2007).
   PubMed Web of Science ®Google Scholar
• Lane CS. Mass spectrometry-based proteomics in the life sciences. Cell. Mol. Life Sci.62, 848–869 (2005).
   PubMed Web of Science ®Google Scholar
• Lubec G, Afjehi-Sadat L. Limitations and pitfalls in protein identification by mass spectrometry. Chem. Rev.107, 3568–3584 (2007).
   PubMed Web of Science ®Google Scholar
• Li TW, Evdokimov E, Shen RF et al. Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis. Proc. Natl Acad. Sci. USA101, 8551–8556 (2004).
   PubMed Web of Science ®Google Scholar
• Zhao YM, Kwon SW, Anselmo A, Kaur K, White MA. Broad spectrum identification of cellular small ubiquitin-related modifier (SUMO) substrate proteins. J. Biol. Chem.279, 20999–21002 (2004).
   PubMedGoogle Scholar
• Bohren KM, Gabbay KH, Owerbach D. Affinity chromatography of native SUMO proteins using His-tagged recombinant UBC9 bound to Co2+-charged talon resin. Protein Expr. Purif.54, 289–294 (2007).
   PubMedGoogle Scholar
• Li TW, Santockyte R, Shen RF et al. A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers. Arch. Biochem. Biophys.453, 70–74 (2006).
   PubMedGoogle Scholar
• Vertegaal ACO, Andersen JS, Ogg SC et al. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell. Proteomics5, 2298–2310 (2006).
   PubMedGoogle Scholar
• Panse VG, Hardeland U, Werner T, Kuster B, Hurt E. A proteome-wide approach identifies sumoylated substrate proteins in yeast. J. Biol. Chem.279, 41346–41351 (2004).
   PubMed Web of Science ®Google Scholar
• Denison C, Kirkpatrick DS, Gygi SP. Proteomic insights into ubiquitin and ubiquitin-like proteins. Curr. Opin. Chem. Biol.9, 69–75 (2005).
   PubMed Web of Science ®Google Scholar
• Ganesan AK, Kho Y, Kim SC et al. Broad spectrum identification of SUMO substrates in melanoma cells. Proteomics7, 2216–2221 (2007).
   PubMedGoogle Scholar
• Hannich JT, Lewis A, Kroetz MB et al. Defining the SUMO-modified proteome by multiple approaches in Saccharomyces cerevisiae. J. Biol. Chem.280, 4102–4110 (2005).
   PubMed Web of Science ®Google Scholar
• Wykoff DD, O’Shea EK. Identification of sumoylated proteins by systematic immunoprecipitation of the budding yeast proteome. Mol. Cell. Proteomics4, 73–83 (2005).
   PubMedGoogle Scholar
• Rosas-Acosta G, Russell WK, Deyrieux A, Russell DH, Wilson VG. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol. Cell. Proteomics4, 56–72 (2005).
   PubMed Web of Science ®Google Scholar
• Zhou W, Ryan JJ, Zhou H. Global analyses of sumoylated proteins in Saccharomyces cerevisiae – induction of protein sumoylation by cellular stresses. J. Biol. Chem.279, 32262–32268 (2004).
   PubMed Web of Science ®Google Scholar
• Vertegaal ACO, Ogg SC, Jaffray E et al. A proteomic study of SUMO-2 target proteins. J. Biol. Chem.279, 33791–33798 (2004).
   PubMed Web of Science ®Google Scholar
• Wohlschlegel JA, Johnson ES, Reed SI, Yates JR. Global analysis of protein sumoylation in Saccharomyces cerevisiae. J. Biol. Chem.279, 45662–45668 (2004).
   PubMedGoogle Scholar
• Manza LL, Codreanu SG, Stamer SL et al. Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chem. Res. Toxicol.17, 1706–1715 (2004).
   PubMed Web of Science ®Google Scholar
• Oh YH, Hong MY, Jin Z et al. Chip-based analysis of SUMO (small ubiquitin-like modifier) conjugation to a target protein. Biosens. Bioelect.22, 1260–1267 (2007).
   PubMedGoogle Scholar
• Gocke CB, Yu HT, Kang JS. Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. J. Biol. Chem.280, 5004–5012 (2005).
   PubMedGoogle Scholar
• Yan J, Yang XP, Kim YS, Joo JH, Jetten AM. RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation. Biochem. Biophys. Res. Commun.362, 132–138 (2007).
   PubMedGoogle Scholar
• Gong L, Yeh ETH. Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J. Biol. Chem.281, 15869–15877 (2006).
   PubMedGoogle Scholar
• Mikolajczyk J, Drag M, Bekes M et al. Small ubiquitin-related modifier (SUMO)-specific proteases – profiling the specificities and activities of human SENPs. J. Biol. Chem.282, 26217–26224 (2007).
   PubMed Web of Science ®Google Scholar
• Saitoh H, Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem.275, 6252–6258 (2000).
   PubMed Web of Science ®Google Scholar
• Deyrieux AF, Rosas-Acosta G, Ozbun MA, Wilson VG. Sumoylation dynamics during keratinocyte differentiation. J. Cell. Sci.120, 125–136 (2007).
   PubMedGoogle Scholar
• Ayaydin F, Dasso M. Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol. Biol. Cell15, 5208–5218 (2004).
   PubMed Web of Science ®Google Scholar
• Langereis MA, Rosas-Acosta G, Mulder K, Wilson VG. Production of sumoylated proteins using a baculovirus expression system. J. Virol. Meth.139, 189–194 (2007).
   PubMedGoogle Scholar
• Kurepa J, Walker JM, Smalle J et al. The small ubiquitin-like modifier (SUMO) protein modification system in Arabidopsis – accumulation of SUMO1 and -2 conjugates is increased by stress. J. Biol. Chem.278, 6862–6872 (2003).
   PubMed Web of Science ®Google Scholar
• Bossis G, Melchior F. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Mol. Cell21, 349–357 (2006).
   PubMed Web of Science ®Google Scholar
• Riquelme C, Barthel KK, Qin XF, Liu X. Ubc9 expression is essential for myotube formation in C2C12. Exp. Cell Res.312(11), 2132–2141 (2006).
   PubMedGoogle Scholar
• Shao RJ, Rung E, Weijdegard B, Billig H. Induction of apoptosis increases SUMO-1 protein expression and conjugation in mouse periovulatory granulosa cells in vitro. Mol. Reprod. Dev.73, 50–60 (2006).
   PubMedGoogle Scholar
• Smolen GA, Vassileva MT, Wells J, Matunis MJ, Haber DA. SUMO-1 modification of the Wilms’ tumor suppressor WT1. Cancer Res.64, 7846–7851 (2004).
   PubMed Web of Science ®Google Scholar
• Alarcon-Vargas D, Ronai Z. SUMO in cancer-wrestlers wanted. Cancer Biol. Ther.1, 237–242 (2002).
   PubMed Web of Science ®Google Scholar
• Mo YY, Yu YN, Theodosiou E, Ee PLR, Beck WT. A role for Ubc9 in tumorigenesis. Oncogene24, 2677–2683 (2005).
   PubMed Web of Science ®Google Scholar
• Baek SH. A novel link between SUMO modification and cancer metastasis. Cell Cycle5, 1492–1495 (2006).
   PubMed Web of Science ®Google Scholar
• Il Kim K, Baek SH. SUMOylation code in cancer development and metastasis. Mol. Cell22, 247–253 (2006).
   Google Scholar
• Wu FT, Mo YY. Ubiquitin-like protein modifications in prostate and breast cancer. Front. Biosci.12, 700–711 (2007).
   PubMedGoogle Scholar
• Karamouzis M, Konstantinopoulos P, Badra F, Papavassiliou A. SUMO and estrogen receptors in breast cancer. Breast Cancer Res. Treat.107(2), 195–210 (2007).
   PubMedGoogle Scholar
• Kamitani T, Kito K, Nguyen HP et al. Identification of three major sentrinization sites in PML. J. Biol. Chem.273, 26675–26682 (1998).
   PubMedGoogle Scholar
• Rangasamy D, Woytek K, Khan SA, Wilson VG. SUMO-1 modification of bovine papillomavirus E1 protein is required for intranuclear accumulation. J. Biol. Chem.275, 37999–38004 (2000).
   PubMedGoogle Scholar
• Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature419, 135–141 (2002).
   PubMed Web of Science ®Google Scholar
• Chung TL, Hsiao HH, Yeh YY et al.In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein – definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides. J. Biol. Chem.279, 39653–39662 (2004).
   PubMed Web of Science ®Google Scholar
• Cooper HJ, Tatham MH, Jaffray E et al. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 AutoSUMOylation reaction. Anal. Chem.77, 6310–6319 (2005).
   PubMedGoogle Scholar
• Pedrioli PGA, Raught B, Zhang XD et al. Automated identification of SUMOylation sites using mass spectrometry and SUMmOn pattern recognition software. Nat. Methods3, 533–539 (2006).
   PubMed Web of Science ®Google Scholar
• Knuesel M, Cheung HT, Hamady M, Barthel KKB, Liu XD. A method of mapping protein sumoylation sites by mass spectrometry using a modified small ubiquitin-like modifier 1 (SUMO-1) and a computational program. Mol. Cell. Proteomics4, 1626–1636 (2005).
   PubMedGoogle Scholar
• Wohlschlegel JA, Johnson ES, Reed SI, Yates JR. Improved identification of SUMO attachment sites using C-terminal SUMO mutants and tailored protease digestion strategies. J. Proteome Res.5, 761–770 (2006).
   PubMedGoogle Scholar
• Ulrich HD. Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest. Trends Cell Biol.15, 525–532 (2005).
   PubMedGoogle Scholar
• Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell2, 233–239 (1998).
   PubMed Web of Science ®Google Scholar
• Lin X, Liang M, Liang YY, Brunicardi FC, Feng XH. SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J. Biol. Chem.278, 31043–31048 (2003).
   PubMedGoogle Scholar
• Steffan JS, Agrawal N, Pallos J et al. SUMO modification of Huntingtin and Huntington’s disease pathology. Science304, 100–104 (2004).
   PubMed Web of Science ®Google Scholar
• Kerscher O, Felberbaum R, Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Ann. Rev. Cell Develop. Biol.22, 159–180 (2006).
   PubMed Web of Science ®Google Scholar
• Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. Sequential modification of NEMO/IKK gamma by SUMO-1 and ubiquitin mediates NF-κB activation by genotoxic stress. Cell115, 565–576 (2003).
   PubMed Web of Science ®Google Scholar
• Kannouche PL, Wing J, Lehmann AR. Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol. Cell14, 491–500 (2004).
   PubMed Web of Science ®Google Scholar
• Papouli E, Chen SH, Davies AA et al. Crosstalk between SUMO and ubiquitin on PCNA is mediated by recruitment of the helicase Srs2p. Mol. Cell19, 123–133 (2005).
   PubMed Web of Science ®Google Scholar
• Nathan D, Ingvarsdottir K, Sterner DE et al. Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev.20, 966–976 (2006).
   PubMed Web of Science ®Google Scholar
• Shiio Y, Eisenman RN. Histone sumoylation is associated with transcriptional repression. Proc. Natl Acad. Sci. USA100, 13225–13230 (2003).
   PubMed Web of Science ®Google Scholar
• Heun P. SUMOrganization of the nucleus. Curr. Opin. Cell Biol.19, 350–355 (2007).
   PubMed Web of Science ®Google Scholar
• Xirodimas DP, Chisholm J, Desterro JMS, Lane DP, Hay RT. P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. FEBS Lett.528, 207–211 (2002).
   PubMedGoogle Scholar
• Buschmann T, Lerner D, Lee CG, Ronai Z. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9. J. Biol. Chem.276, 40389–40395 (2001).
   PubMedGoogle Scholar
• Agrawal A, Yang JH, Murphy RF, Agrawal DK. Regulation of the p14ARF–Mdm2–p53 pathway: an overview in breast cancer. Exp. Mol. Path.81, 115–122 (2006).
   PubMed Web of Science ®Google Scholar
• Carter S, Bischof O, Dejean A, Vousden KH. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat. Cell Biol.9, 428–435 (2007).
   PubMed Web of Science ®Google Scholar
• Miyauchi Y, Yogosawa S, Honda R, Nishida T, Yasuda H. Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes. J. Biol. Chem.277, 50131–50136 (2002).
   PubMed Web of Science ®Google Scholar
• Lee MH, Lee SW, Lee EJ et al. SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination. Nat.Cell Biol.8, U1424–U1472 (2006).
   PubMedGoogle Scholar
• Um JW, Chung KC. Functional modulation of parkin through physical interaction with SUMO-1. J. Neuro. Res.84, 1543–1554 (2006).
   PubMedGoogle Scholar
• Um JW, Min DS, Rhim H et al. Parkin ubiquitinates and promotes the degradation of RanBP2. J. Biol. Chem.281, 3595–3603 (2006).
   PubMed Web of Science ®Google Scholar
• Pichler A, Knipscheer P, Oberhofer E et al. SUMO modification of the ubiquitin-conjugating enzyme E2–25K. Nat. Struct. Mol. Biol.12, 264–269 (2005).
   PubMed Web of Science ®Google Scholar
• de Pril R, Fischer DF, Roos RA, van Leeuwen FW. Ubiquitin-conjugating enzyme E2–25K increases aggregate formation and cell death in polyglutamine diseases. Mol. Cell. Neurosci.34, 10–19 (2007).
   PubMedGoogle Scholar
• Pungaliya P, Kulkarni D, Park HJ et al. TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins. J. Proteome Res.6, 3918–3923 (2007).
   PubMed Web of Science ®Google Scholar
• Rajendra R, Malegaonkar D, Pungaliya P et al. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53. J. Biol. Chem.279, 36440–36444 (2004).
   PubMed Web of Science ®Google Scholar
• Weger S, Hammer E, Heilbronn R. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo. FEBS Lett.579, 5007–5012 (2005).
   PubMed Web of Science ®Google Scholar
• Zhao XL, Blobel G. A SUMO ligase is part of a nuclear multiprotein complex that affects DNA repair and chromosomal organization. Proc. Natl Acad. Sci. USA102, 9086–9086 (2005).
   Google Scholar
• Prudden J, Pebernard S, Raffa G et al. SUMO-targeted ubiquitin ligases in genome stability. EMBO J.26, 4089–4101 (2007).
   PubMed Web of Science ®Google Scholar
• Sun H, Leverson JD, Hunter T. Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J.26, 4102–4112 (2007).
   PubMed Web of Science ®Google Scholar
• Xie Y, Kerscher O, Kroetz MB et al. The yeast HEX3–SLX8 heterodimer is a ubiquitin ligase stimulated by substrate sumoylation. J. Biol. Chem.282, 34176–34184 (2007).
   PubMed Web of Science ®Google Scholar
• Uzunova K, Gottsche K, Miteva M et al. Ubiquitin-dependent proteolytic control of SUMO conjugates. J. Biol. Chem.282, 34167–34175 (2007).
   PubMed Web of Science ®Google Scholar